Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans
NCT00925808 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1187
Last updated 2019-08-30
Summary
This is a prospective study with the following objectives:
Primary Objective:
1. To estimate the prevalence of unsuspected VTE in oncology patients on routine staging CT scans of the thorax, abdomen and pelvis.
Secondary Objectives:
2. To identify symptoms commonly associated with VTE that are present in cancer patients undergoing routine staging CT scans with findings of unsuspected VTE.
3. To identify the risk factors and demographic characteristics in outpatient cancer patients associated with the development of unsuspected VTE.
4. To determine the incidence of recurrence of new VTE in patients with unsuspected VTE at 3 and 6 months of follow-up.
Conditions
- Cancer
- Venous Thromboembolism
Interventions
- BEHAVIORAL
-
Questionnaires
Survey tools and VTE Symptom Follow-up Questionnaire
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Carmen Escalante, MD · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2020-06-30
- Completion
- 2021-06-30
Countries
- United States
Study Locations
More Related Trials
-
VEGF Early Imaging for Breast Cancer
NCT00991978 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Predictive Value of CT-PET in Esophageal Cancer
NCT02385604 ·Status: COMPLETED
-
PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas
NCT03076333 ·Status: COMPLETED ·Phase: NA
-
4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis
NCT00862680 ·Status: COMPLETED
-
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
NCT05212103 ·Status: ENROLLING_BY_INVITATION
-
The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules
NCT00598065 ·Status: COMPLETED ·Phase: NA
-
PET/CT Evaluation of Treatment Response in Breast Cancer
NCT01222416 ·Status: TERMINATED ·Phase: NA
-
PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma
NCT00828126 ·Status: COMPLETED
-
Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer
NCT02655068 ·Status: TERMINATED ·Phase: PHASE3
-
PET/MR in Radiotherapy for Head and Neck Cancer Pilot
NCT02952625 ·Status: COMPLETED ·Phase: NA
-
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
NCT07303725 ·Status: RECRUITING
-
Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition
NCT02285660 ·Status: UNKNOWN ·Phase: NA
-
DCE-MRI for Assessment of Response to TACE of HCC
NCT02878109 ·Status: COMPLETED
-
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer
NCT02088775 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies
NCT05629689 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug
NCT00988936 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors
NCT04993261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
NCT02055586 ·Status: COMPLETED
-
FDG-PET-CT and Biomarkers in Esophageal Cancer
NCT00833625 ·Status: COMPLETED ·Phase: NA
-
PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
NCT00346125 ·Status: COMPLETED ·Phase: NA
-
Correlation of PET-CT Studies With Serum Protein Analysis
NCT00547742 ·Status: COMPLETED
-
Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study
NCT00686465 ·Status: COMPLETED ·Phase: NA
-
FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer
NCT00282906 ·Status: COMPLETED ·Phase: NA
-
Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
NCT04258462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT
NCT02119065 ·Status: ACTIVE_NOT_RECRUITING